Pharmaceutical giant Pfizer and French partner Valneva on Monday said they planned to seek regulatory approval for a Lyme ...

Lyme disease is an illness caused by bacteria most commonly spread to humans from ticks. It can cause arthritis, muscle ...

Pfizer is working to get approval on a new vaccine that could protect people against Lyme disease, but the company could see ...

Pfizer says it's going to seek approval for its Lyme disease vaccine. That's despite the shot failing a late-stage trial.

Pfizer said its experimental Lyme disease vaccine was more than 70% efficacious in reducing confirmed cases of the tickborne ...

The partners said the shot produced “clinically meaningful” efficacy despite missing its main study objective, a finding they ...

The drugmaker is seeking regulatory review for the first new shot to combat the disease in decades.

Pfizer and Valneva have blamed “fewer than anticipated” Lyme disease cases for the failure of their phase 3 trial to hit its ...